胃酸缺乏

Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842-1860.

• 摘要

El-Zimaity H. Gastritis and gastric atrophy. Curr Opin Gastroenterol. 2008;24:682-686.

• 摘要

Sepulveda AR, Patil M. Practical approach to the pathologic diagnosis of gastritis. Arch Pathol Lab Med. 2008;132:1586-1593.

• 摘要

Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007;102:2047-2056.

• 摘要

Weck MN, Stegmaier C, Rothenbacher D, et al. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther. 2007;26:879-887.

• 摘要

Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol. 2009;24:193-201.

• 摘要

D'Elios MM, Bergman MP, Azzurri A, et al. H+,K+-ATPase (proton-pump) is the target autoantigen of TH1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology. 2001;120:377-386.

• 摘要

Malfertheiner P, Megraud F, O'Morain CA, et al; European Helicobacter Study Group. Management of Helicobacter pylori infection - the Maastricht IV/Florence Consensus Report. Gut. 2012;61:646-664.

• 全文
• 摘要

Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808-1825.

• 全文
• 摘要

1.  Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842-1860.

• 摘要

2.  Brand SJ, Stone D. Reciprocal regulation of antral gastrin and somatostatin gene expression by omeprazole-induced achlorhydria. J Clin Invest. 1988;82:1059-1066.

• 全文
• 摘要

3.  Wu SV, Giraud A, Mogard M, et al. Effects of inhibition of gastric secretion on antral gastrin and somatostatin gene expression in rats. Am J Physiol. 1990;258:G788-G793.

• 摘要

4.  Manela FD, Ren J, Gao J, et al. Calcitonin gene-related peptide modulates acid-mediated regulation of somatostatin and gastrin release from rat antrum. Gastroenterology. 1995;109:701-706.

• 摘要

5.  El-Zimaity H. Gastritis and gastric atrophy. Curr Opin Gastroenterol. 2008;24:682-686.

• 摘要

6.  Sepulveda AR, Patil M. Practical approach to the pathologic diagnosis of gastritis. Arch Pathol Lab Med. 2008;132:1586-1593.

• 摘要

7.  Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol. 2005;36:228-233.

• 摘要

8.  Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40:650-658.

• 摘要

9.  Betesh AL, Santa Ana CA, Cole JA, et al. Is achlorhydria a cause of iron deficiency anemia? Am J Clin Nutr. 2015;102:9-19.

• 全文
• 摘要

10.  Howard TA, Misra DN, Grove M, et al. Human gastric intrinsic factor expression is not restricted to parietal cells. J Anat. 1996;189:303-313.

• 全文
• 摘要

11.  Richards JB, Goltzman D. Proton-pump inhibitors: balancing the benefits and potential fracture risks. CMAJ. 2008;179:306-307.

• 全文
• 摘要

12.  Yang YX, Lewis JD, Epstein S, et al. Long-term proton-pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947-2953.

• 摘要

13.  Targownik LE, Lix LM, Metge CJ, et al. Use of proton-pump inhibitors and risk of osteoporosis-related fractures. CMAJ. 2008;179:319-326.

• 全文
• 摘要

14.  Friis-Hansen L. Achlorhydria is associated with gastric microbial overgrowth and development of cancer: lessons learned from the gastrin knockout mouse. Scand J Clin Lab Invest. 2006;66:607-621.

• 摘要

15.  Pohl D, Fox M, Fried M, et al. Do we need gastric acid? Digestion. 2008;77:184-197.

• 摘要

16.  Williams C, McColl KE. Review article: proton-pump inhibitors and bacterial overgrowth. Aliment Pharmacol Ther. 2006;23:3-10.

• 摘要

17.  Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007;102:2047-2056.

• 摘要

18.  Dial S, Delaney JA, Barkun AN, et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294:2989-2995.

• 摘要

19.  Gulmez SE, Holm A, Frederiksen H, et al. Use of proton-pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med. 2007;167:950-955.

• 摘要

20.  Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008;149:391-398.

• 摘要

21.  Weck MN, Stegmaier C, Rothenbacher D, et al. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther. 2007;26:879-887.

• 摘要

22.  Bhutto A, Morley JE. The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care. 2008;11:651-660.

• 摘要

23.  Webb PM, Hengels KJ, Moller H, et al. The epidemiology of lower serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterology. 1994;107:1335-1344.

• 摘要

24.  Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol. 2009;24:193-201.

• 摘要

25.  Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996;156:1097-1100.

• 摘要

26.  Zhang Y, Weck MN, Schöttker B, et al. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013;22:821-826.

• 全文
• 摘要

27.  Toh BH, Alderuccio F. Pernicious anemia. Autoimmunity. 2004;37:357-361.

• 摘要

28.  Davidson RJ, Atrah HI, Sewell HF. Longitudinal study of circulating gastric antibodies in pernicious anaemia. J Clin Pathol. 1989;42:1092-1095.

• 全文
• 摘要

29.  Lombardo L, Leto R, Molinaro G, et al. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med. 2010;48:1327-1332.

• 摘要

30.  Kuipers EJ, Pérez-Pérez GI, Meuwissen SG, et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995;87:1777-1780.

• 摘要

31.  Adamu MA, Weck MN, Gao L, et al. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol. 2010;25:439-448.

• 摘要

32.  Song H, Held M, Sandin S, et al. Increase in the prevalence of atrophic gastritis among adults age 35 to 44 years old in northern Sweden between 1990 and 2009. Clin Gastroenterol Hepatol. 2015;13:1592-1600.

• 摘要

33.  Venerito M, Varbanova M, Röhl FW, et al. Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis. J Clin Pathol. 2016;69:677-685.

• 摘要

34.  Argent RH, Thomas RJ, Aviles-Jimenez F, et al. Toxigenic Helicobacter pylori infection precedes gastric hypochlorhydria in cancer relatives, and H pylori virulence evolves in these families. Clin Cancer Res. 2008;14:2227-2235.

• 摘要

35.  Lewerin C, Jacobsson S, Lindstedt G, et al. Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: implications for vitamin B12, folic acid, and iron status and response to oral vitamin therapy. Scand J Gastroenterol. 2008;43:1050-1056.

• 摘要

36.  D'Elios MM, Bergman MP, Azzurri A, et al. H+,K+-ATPase (proton-pump) is the target autoantigen of TH1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology. 2001;120:377-386.

• 摘要

37.  Claeys D, Faller G, Appelmelk BJ, et al. The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology. 1998;114:340-347.

• 摘要

38.  Miner P Jr, Katz PO, Chen Y, et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol. 2003:98:2616-2620.

• 摘要

39.  Shi S, Klotz U. Proton-pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008;64:935-951.

• 摘要

40.  Fellenius E, Berglindh T, Sachs G. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+K+)ATPase. Nature. 1981;290:159-161.

• 摘要

41.  Murphy G, Dawsey SM, Engels EA, et al. Cancer risk after pernicious anemia in the US elderly population. Clin Gastroenterol Hepatol. 2015;13:2282-2289.

• 摘要

42.  Hou W, Schubert ML. Treatment of gastric carcinoids. Curr Treat Options Gastroenterol. 2007;10:123-133.

• 摘要

43.  Lahner E, Bordi C, Cattaruzza MS, et al. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther. 2005;22:471-481.

• 摘要

44.  Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010;31:1042-1050.

• 摘要

45.  Lahner E, Annibale B, Delle Fave G. Systemic review: Helicobacter pylori infection and impaired drug absorption. Aliment Pharmacol Ther. 2009;29:379-386.

• 摘要

46.  Lahner E, Annibale B, Delle Fave G. Systemic review: impaired drug absorption related to the co-administration of antisecretory therapy. Aliment Pharmacol Ther. 2009;28:1219-1229.

• 摘要

47.  Oosterhuis B, Jonkman JH, Andersson T, et al. Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose. Br J Clin Pharmac. 1991;32:569-572.

• 摘要

48.  Soons PA, van den Berg G, Danhof M, et al. Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects. Eur J Clin Pharmacol. 1992;42:319-324.

• 摘要

49.  Graham DY, Alpert LC, Smith JL, et al. Iatrogenic Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol. 1988;83:192-199.

50.  Saha A, Hammond CE, Trojanowska M, et al. Helicobacter pylori-induced H,K-ATPase alpha-subunit gene repression is mediated by NF-kappaB p50 homodimer promoter binding. Am J Physiol Gastrointest Liver Physiol. 2008;294:G795-G807.

• 摘要

51.  Kobayashi H, Kamiya S, Suzuki T, et al. The effect of Helicobacter pylori on gastric acid secretion by isolated parietal cells from a guinea pig: association with production of vacuolating toxin by H pylori. Scand J Gastroenterol. 1996;31:428-433.

• 摘要

52.  Beales IL, Calam J. Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C. Gut. 2001;48:782-789.

• 摘要

53.  Liaskos C, Norman GL, Moulas A, et al. Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis. Clin Chim Acta. 2010;411:411-415.

• 摘要

54.  Kasperlik-Zaluska AA, Czarnocka B, Czech W, et al. Secondary adrenal insufficiency associated with autoimmune disorders: a report of twenty-five cases. Clin Endocrinol (Oxf). 1998;49:779-783.

• 摘要

55.  De Block CE, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. Clin Endocrinol Metab. 2008;93:363-371.

• 摘要

56.  Chan JC, Liu HS, Kho BC, et al. Pattern of thyroid autoimmunity in Chinese patients with pernicious anemia. Am J Med Sci. 2009;337:432-437.

• 摘要

57.  Checchi S, Montanaro A, Ciuoli C, et al. Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis. Thyroid. 2010;20:1385-1389.

• 摘要

58.  Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev. 2014;13:459-462.

• 摘要

59.  Venerito M, Radünz M, Reschke K, et al. Autoimmune gastritis in autoimmune thyroid disease. Aliment Pharmacol Ther. 2015;41:686-693.

• 摘要

60.  Annibale B, Lahner E, Santucci A, et al. CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter. 2007;12:23-30.

• 摘要

61.  Green LK, Graham DY. Gastritis in the elderly. Gastroenterol Clin North Am. 1990;19:273-292.

• 摘要

62.  Karnes WE Jr, Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology. 1991;101:167-174.

• 摘要

63.  Cover TL, Blaser MJ. Helicobacter in health and disease. Gastroenterology. 2009;136:1863-1873.

• 摘要

64.  Woo JS, el-Zimaity HM, Genta RM, et al. The best gastric site for obtaining a positive rapid urease test. Helicobacter. 1996;1:256-259.

• 摘要

65.  Vilaichone RK, Mahachai V, Graham DY. Helicobacter pylori diagnosis and treatment. Gastroenterol Clin North Am. 2006;35:229-247.

• 摘要

66.  Kokkola A, Sjöblom SM, Haapiainen R, et al. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol. 1998;33:88-92.

• 摘要

67.  Eshmuratov A, Nah JC, Kim N, et al. The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci. 2010;55:1364-1375.

• 摘要

68.  Hutchinson C, Geissler CA, Powell JJ, et al. Proton-pump inhibitors suppress absorption of dietary non-haem iron in hereditary hemochromatosis. Gut. 2007;56:1291-1295.

• 摘要

69.  Sharma VR, Brannon MA, Carloss EA. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J. 2004;97:887-889.

• 摘要

70.  Annibale B, Capurso G, Chistolini A, et al. Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms. Am J Med. 2001;111:439-445.

• 摘要

71.  Hershko C, Skikne B. Pathogenesis and management of iron deficiency anemia: emerging role of celiac disease, helicobacter pylori, and autoimmune gastritis. Semin Hematol. 2009;46:339-350.

• 摘要

72.  Schubert ML, Edwards NF, Makhlouf GM. Regulation of gastric somatostatin secretion in the mouse by luminal acid: a local feedback mechanism. Gastroenterology. 1988;94:317-322.

• 摘要

73.  Zaki M, Harrington L, McCuen R, et al. Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum. Gastroenterology. 1996;111:919-924.

• 摘要

74.  Martinez V, Curi AP, Torkian B, et al. High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice. Gastroenterology. 1998;114:1125-1132.

• 摘要

75.  Klinkenberg-Knol EC, Festen HP, Jansen JB, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med. 1994;121:161-167.

• 摘要

76.  McCloy RF, Arnold R, Bardhan KD, et al. Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci. 1995;40:96S-120S.

• 摘要

77.  Hung PD, Schubert ML, Mihas AA. Zollinger-Ellison syndrome. Curr Treat Options Gastroenterol. 2003;6:163-170.

• 摘要

78.  Scott JM. Folate and vitamin B12. Proc Nutri Soc. 1999;58:441-448.

• 摘要

79.  Den Elzen WP, Groeneveld Y, De Ruijter W, et al. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals. Aliment Pharmacol Ther. 2008;27:491-497.

• 摘要

80.  Lahner E, Annibale B. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol. 2009;15:5121-5128.

• 全文
• 摘要

81.  Hershko C, Ronson A, Souroujon M, et al. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006;107:1673-1679.

• 全文
• 摘要

82.  Lahner E, Norman GL, Severi C, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009;104:2071-2079.

• 摘要

83.  Oh DS, Wang HS, Ohning GV, et al. Validation of a new endoscopic technique to assess acid output in Zollinger-Ellison Syndrome. Clin Gastroenterol Hepatol. 2006;4:1467-1473.

• 摘要

84.  Moore EW, Scarlata RW. The determination of gastric acidity by the glass electrode. Gastroenterology. 1965;49:178-188.

• 摘要

85.  Al-Omari FA, Matalka II, Al-Jarrah MA, et al. An intelligent decision support system for quantitative assessment of gastric atrophy. J Clin Pathol. 2011;64:330-337.

• 摘要

86.  Bettington M, Brown I. Autoimmune gastritis: novel clues to histological diagnosis. Pathology. 2013;45:145-149.

• 摘要

87.  Malfertheiner P, Megraud F, O'Morain CA, et al; European Helicobacter Study Group. Management of Helicobacter pylori infection - the Maastricht IV/Florence Consensus Report. Gut. 2012;61:646-664.

• 全文
• 摘要

88.  Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808-1825.

• 全文
• 摘要

89.  Elitsur Y, Tolia V, Gilger MA, et al. Urea breath test in children: the United States prospective, multicenter study. Helicobacter. 2009;14:134-140.

• 摘要

90.  Shimoyama T, Oyama T, Matsuzaka M, et al. Comparison of a stool antigen test and serology for the diagnosis of Helicobacter pylori infection in mass survey. Helicobacter. 2009;14:87-90.

• 摘要

91.  Granstrom M, Lehours P, Bengtsson C, et al. Diagnosis of Helicobacter pylori. Helicobacter. 2008;13:7-12.

• 摘要

92.  Stenstrom B, Mendis A, Marshall B. Helicobacter pylori - the latest in diagnosis and treatment. Aus Fam Physician. 2008;37:608-612.

• 摘要

93.  Calvet X, Ramírez Lázaro MJ, Lehours P, et al. Diagnosis and epidemiology of Helicobacter pylori infection. Helicobacter. 2013;18(suppl 1):5-11.

• 全文
• 摘要

94.  Kanna S, Maradey-Romero C, Fass R. Diagnostic tests for Helicobacter pylori. Gastroenterol Endosc News. 2013;11(Special edition):51-58.

• 全文

95.  Ferreira RM, Machado JC, Letley D, et al. A novel method for genotyping the Helicobacter pylori vacA intermediate region directly in gastric biopsy specimens. J Clin Microbiol. 2012;50:3983-3989.

• 全文
• 摘要

96.  Chen T, Meng X, Zhang H, et al. Comparing multiplex PCR and rapid urease test in the detection of H. pylori in patients on proton pump inhibitors. Gastroenterol Res Pract. 2012;2012:898276.

• 全文
• 摘要

97.  Tajbakhsh S, Samarbaf-Zadeh AR, Moosavian M. Comparison of fluorescent in situ hybridization and histological method for the diagnosis of Helicobacter pylori in gastric biopsy samples. Med Sci Monit. 2008;14:BR183-BR187.

• 摘要

98.  Cerqueira L, Fernandes RM, Ferreira RM, et al. Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. J Clin Microbiol. 2013;51:1887-1893.

• 全文
• 摘要

99.  Richter C, Tanaka T, Yada RY. Mechanism of activation of the gastric aspartic proteinases: pepsinogen, progastricsin and prochymosin. Biochem J. 1998;355:481-490.

• 全文
• 摘要

100.  Etherington DJ, Taylor WH. Nomenclature of the pepsins. Nature. 1967;216:279-280.

• 摘要

101.  Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis. 2007;8:8-14.

• 摘要

102.  Sipponen P, Ranta P, Helske T, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol. 2002;37:785-791.

• 摘要

103.  Vaananen H, Vauhkonen M, Helske T, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test: correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol. 2003;15:885-891.

• 摘要

104.  Leja M, Kupcinskas L, Funka K, et al. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Dig Dis Sci. 2009;54:2377-2384.

• 摘要

105.  Antico A, Tampoia M, Villalta D, et al. Clinical usefulness of the serological gastric biopsy for the diagnosis of chronic autoimmune gastritis. Clin Dev Immunol. 2012;2012:520970.

• 全文
• 摘要

106.  Agreus L, Kuipers EJ, Kupcinskas L, et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol. 2012;47:136-147.

• 全文
• 摘要

107.  McNicholl AG, Forné M, Barrio J, et al. Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol. 2014;26:941-948.

• 全文
• 摘要

108.  Kawashima J, Ohno S, Sakurada T, et al. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol. 2009;44:1046-1054.

• 摘要

109.  Takiguchi S, Adachi S, Yamamoto K, et al. Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers. Dig Dis Sci. 2012;57:1238-1246.

• 摘要

110.  Kumar V. Pernicious anemia. MLO Med Lab Obs. 2007;39:28, 30-31.

• 摘要

111.  Scalabrino G. Cobalamin (vitamin B12) in subacute combined degeneration and beyond: traditional interpretations and novel theories. Exp Neurol. 2005;192:463-479.

• 摘要

112.  Holt PR. Intestinal malabsorption in the elderly. Dig Dis. 2007;25:144-150.

• 摘要

113.  Goel GA, Deshpande A, Lopez R, et al. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin Gastroenterol Hepatol. 2012;10:422-427.

• 全文
• 摘要

114.  Zucker DK, Livingston RL, Nakra R, et al. B12 deficiency and psychiatric disorders: case report and literature review. Biol Psychiatry. 1981;16:197-205.

• 摘要

115.  Graells J, Ojeda RM, Muniesa C, et al. Glossitis with linear lesions: an early sign of vitamin B12 deficiency. J Am Acad Dermatol. 2009;60:498-500.

• 摘要

116.  Kumar G, Vaidyanathan L, Stead LG. Images in emergency medicine: koilonychia, or spoon-shaped nails, is generally associated with iron-deficiency anemia. Ann Emerg Med. 2007;49:243,250.

• 摘要

117.  Mannath J, Ragunath K. Narrow band imaging and high resolution endoscopy with magnification could be useful in identifying gastric atrophy. Dig Dis Sci. 2010;55:1799-1800.

• 摘要

118.  Klein K. Gastric secretory testing. In: Drossman DA, ed. Manual of gastroenterologic procedures. 2nd ed. New York, NY: Raven Press; 1987.

119.  Xu D, Fyfe JC. Cubilin expression and posttranslational modification in the canine gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol. 2000;279:G748-G756.

• 摘要

120.  Moestrup SK. New insights into carrier binding and epithelial uptake of the erythropoietic nutrients cobalamin and folate. Curr Opin Hematol. 2006;13:119-123.

• 摘要

121.  Ozturk E, Yesilova Z, Ilgan S, et al. Performance of acidified (14)C-urea capsule breath test during pantoprazole and ranitidine treatment. J Gastroenterol Hepatol. 2009;24:1248-1251.

• 摘要

122.  Ou Z, Xiong L, Li DY, et al. Evaluation of a new fluorescence quantitative PCR test for diagnosing Helicobacter pylori infection in children. BMC Gastroenterol. 2013;13:7.

• 全文
• 摘要

123.  O'Connell MB, Madden DM, Murray AM, et al. Effects of proton-pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. 2005;118:778-781.

• 摘要

124.  ASGE Standards of Practice Committee, Evans JA, Chandrasekhara V, et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc. 2015;82:1-8.

• 摘要

125.  Hirota WK, Zuckerman MJ, Adler DG, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63:570-580.

• 摘要

126.  Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44:74-94.

• 全文
• 摘要

127.  Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353-1367.

• 全文
• 摘要

128.  Toyokawa T, Suwaki K, Miyake Y, et al. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study. J Gastroenterol Hepatol. 2010;25:544-547.

• 摘要

129.  De Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol. 2009;104:1342-1345.

• 摘要

130.  Shiota S, Reddy R, Alsarraj A, et al. Antibiotic resistance of Helicobacter pylori among male United States veterans. Clin Gastroenterol Hepatol. 2015;13:1616-1624.

• 摘要

131.  Malfertheiner P. Helicobacter pylori infection - management from a European perspective. Dig Dis. 2014;32:275-280.

• 摘要

132.  Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol. 2014;12:177-186.e3.

• 全文
• 摘要

133.  Liang X, Xu X, Zheng Q, et al. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study. Clin Gastroenterol Hepatol. 2013;11:802-807.e1.

• 全文
• 摘要

134.  Vakil N. H. pylori treatment: new wine in old bottles? Am J Gastroenterol. 2009;104:26-30.

• 摘要

135.  Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology. 2007;133:985-1001.

• 摘要

136.  Graham DY, Rimbara E. Understanding and appreciating sequential therapy for Helicobacter pylori eradication. J Clin Gastroenterol. 2011;45:309-313.

• 摘要

137.  Hsu PI, Wu DC, Wu JY, et al. Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter. 2011;16:139-145.

• 摘要

138.  Checchi S, Montanaro A, Pasqui L, et al. L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab. 2008;93:465-469.

• 摘要

139.  Gisbert JP, Romano M, Gravina AG, et al. Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment Pharmacol Ther. 2015;41:768-775.

• 摘要

140.  Fishbane S, Ungureanu VD, Maeska JK, et al. The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis. 1996;28:529-534.

• 摘要

141.  Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis. 1999;33:464-470.

• 摘要

142.  Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149:242-250.

• 摘要

143.  Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670-676.

• 摘要

144.  Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370:657-666.

• 摘要

145.  Lochhead P, El-Omar EM. Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol. 2007;21:281-297.

• 摘要

146.  Sjöblom SM, Sipponen P, Järvinen H. Gastroscopic follow up of pernicious anaemia patients. Gut. 1993;34:28-32.

• 摘要

147.  Merriman NA, Putt ME, Metz DC, et al. Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology. 2010;138:1330-1337.

• 全文
• 摘要

148.  Kim GS, Kim CH, Park JY, et al. Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism. 1996;45:1443-1446.

• 摘要

149.  Wright MJ, Sullivan RR, Gaffney-Stomberg E, et al. Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial. J Bone Miner Res. 2010;25:2205-2211.

• 摘要

150.  Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med. 1997;337:1441-1448.

• 摘要

151.  Heidelbaugh JJ, Kim AH, Chang R, et al. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012;5:219-232.

• 全文
• 摘要